Document is current
Any future updates will be listed below
-
Authors
Klonoff, David C. https://orcid.org/0000-0001-6394-6862
Scheideman, Agatha F. https://orcid.org/0009-0008-4211-4934
Shao, Mandy M. https://orcid.org/0009-0004-9550-9965
Ho, Cindy N. https://orcid.org/0009-0008-3067-1004
Ayers, Alessandra T. https://orcid.org/0009-0000-3054-3207
Jendle, Johan https://orcid.org/0000-0003-1025-1682
Wykowski, Henry G. https://orcid.org/0009-0002-6557-7348
Heinemann, Lutz https://orcid.org/0000-0003-2493-1304
- License Information
-
More Information
Article History
Received: 12 October 2025
Accepted: 13 November 2025
First Online: 3 January 2026
Declarations
:
: Not applicable.
: Not applicable.
: D.C.K. is a consultant for Afon, Embecta, Glooko, Glucotrack, Lifecare, Synchneuro, and Thirdwayv. C.N.H. is a consultant for Liom. A.T.A. is a consultant for Liom. J.J. has been a lecturer/member of the scientific advisory boards at the following companies: Abbott, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Medtronic, Nordic InfuCare, Novo Nordisk, and Sanofi. L.H. is a consultant for Abbott, Lifecare (also a member of the Board of Directors), Medtronic EU Advisory Board, Dexcom Germany, Roche Diagnostics, Liom, and Perfood. He is a shareholder of the Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany, Science Consulting in Diabetes GmbH, Düsseldorf, Germany, and diateam GmbH, Bad Mergentheim, Germany. A.F.S., M.M.S., and H.G.W. have nothing to disclose.
